Leerink Partners Maintains Outperform on AdaptHealth, Raises Price Target to $8
Benzinga Newsdesk 1 hour ago
Analyst RatingsNewsPrice Target
Leerink Partners analyst Whit Mayo maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and raises the price target from $7 to $8.
Leerink Partners analyst Whit Mayo maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and raises the price target from $7 to $8.